Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
Liu Y, Chen K, Li F, Gu Z, Liu Q, He L, Shao T, Song Q, Zhu F, Zhang L, Jiang M, Zhou Y, Barve S, Zhang X, McClain CJ, Feng W.
Hepatology. 2020 Jun;71(6):2050-2066. doi: 10.1002/hep.30975. Epub 2020 Mar 16.
Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease.
Paumgartner G, Beuers U.
Clin Liver Dis. 2004 Feb;8(1):67-81, vi. doi: 10.1016/S1089-3261(03)00135-1.
Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease.
Danielsson O, Vesterinen T, Arola J, Åberg F, Nissinen MJ.
Eur J Gastroenterol Hepatol. 2024 Jul 1;36(7):961-969. doi: 10.1097/MEG.0000000000002785. Epub 2024 Apr 26.
Melatonin improves cholestatic liver disease via the gut-liver axis.
Liu X, Li J, Shi M, Fu J, Wang Y, Kang W, Liu J, Zhu F, Huang K, Chen X, Liu Y.
J Pineal Res. 2024 Jan;76(1):e12929. doi: 10.1111/jpi.12929. Epub 2023 Dec 4.
Drug-induced hepatotoxicity.
Kaplowitz N, Aw TY, Simon FR, Stolz A.
Ann Intern Med. 1986 Jun;104(6):826-39. doi: 10.7326/0003-4819-104-6-826.
Fibrates and cholestasis.
Ghonem NS, Assis DN, Boyer JL.
Hepatology. 2015 Aug;62(2):635-43. doi: 10.1002/hep.27744. Epub 2015 Mar 23.
Bone Health in Patients With Liver Diseases.
Danford CJ, Trivedi HD, Bonder A.
J Clin Densitom. 2020 Apr-Jun;23(2):212-222. doi: 10.1016/j.jocd.2019.01.004. Epub 2019 Jan 18.
Sex-determining region Y gene promotes liver fibrosis and accounts for sexual dimorphism in its pathophysiology.
Wu XN, Wang MZ, Zhang N, Zhang W, Dong J, Ke MY, Xiang JX, Ma F, Xue F, Hou JJ, Ma ZJ, Wang FM, Liu XM, Wu R, Pawlik TM, Ye K, Yu J, Zhang XF, Lyu Y.
J Hepatol. 2024 Jun;80(6):928-940. doi: 10.1016/j.jhep.2024.01.036. Epub 2024 Feb 8.
Pediatric Cholestatic Diseases: Common and Unique Pathogenic Mechanisms.
Sutton H, Karpen SJ, Kamath BM.
Annu Rev Pathol. 2024 Jan 24;19:319-344. doi: 10.1146/annurev-pathmechdis-031521-025623.
The ascending pathophysiology of cholestatic liver disease.
Jansen PL, Ghallab A, Vartak N, Reif R, Schaap FG, Hampe J, Hengstler JG.
Hepatology. 2017 Feb;65(2):722-738. doi: 10.1002/hep.28965.
